发明名称 |
Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist |
摘要 |
The present invention provides 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1,5-a]-pyrazolo-1,3,5-triazine benzenesulfonate salt and a crystalline polymorph thereof. Further provided are pharmaceutical compositions containing the salt and methods of treating CRF-related disorders using said salt.
|
申请公布号 |
US7153961(B2) |
申请公布日期 |
2006.12.26 |
申请号 |
US20040985115 |
申请日期 |
2004.11.10 |
申请人 |
BRISTOL-MYERS SQUIBB PHARMA CO. |
发明人 |
GILLIGAN PAUL J.;RABEL RILEY SHELLY RENEE;MEENAN PAUL A. |
分类号 |
C07D487/04;A61K31/53;A61P3/04;A61P25/22;A61P25/24 |
主分类号 |
C07D487/04 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|